232 related articles for article (PubMed ID: 19481472)
1. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
[TBL] [Abstract][Full Text] [Related]
2. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
4. Comparison of local thrombolytic efficacy of plasmin and rt-PA in an in-vitro flow system; a pilot study.
Bizjak N; Bajd F; Vidmar J; Blinc A; Marder VJ; Novokhatny V; Serša I
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):711-4. PubMed ID: 23751605
[TBL] [Abstract][Full Text] [Related]
5. Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.
Landskroner K; Olson N; Jesmok G
J Vasc Interv Radiol; 2005 Mar; 16(3):369-77. PubMed ID: 15758133
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2-5.
Marder VJ; Manyak S; Gruber T; Goyal A; Moreno G; Hunt J; Bromirski J; Scuderi P; Petteway SR; Novokhatny V
Thromb Haemost; 2010 Oct; 104(4):780-7. PubMed ID: 20806125
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: an endovascular model.
Lin PH; Chen C; Surowiec SM; Conklin B; Bush RL; Lumsden AB
J Vasc Surg; 2001 Mar; 33(3):621-7. PubMed ID: 11241136
[TBL] [Abstract][Full Text] [Related]
8. Effect of intraluminal application of tissue-type plasminogen activator on the fibrinolytic activity of experimental vein grafts.
Underwood MJ; Cooper G; More R; Coumbe A; Toner C; Reynolds P; de Bono D
Cardiovasc Res; 1995 Mar; 29(3):422-7. PubMed ID: 7781016
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 study of human plasma-derived plasmin (TAL-05-00018) in hemodialysis graft occlusion.
Shlansky-Goldberg R
Thromb Res; 2008; 122 Suppl 3():S16-9. PubMed ID: 18760830
[TBL] [Abstract][Full Text] [Related]
10. Desirudin reduces the rate of microvenous thrombosis in a rat model.
Lewis CM; Deschler DG
Laryngoscope; 2008 Jul; 118(7):1149-52. PubMed ID: 18401270
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
Dupe RJ; English PD; Smith RA; Green J
Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
[TBL] [Abstract][Full Text] [Related]
12. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
Novokhatny VV; Jesmok GJ; Landskroner KA; Marder VJ; Zimmerman TP
Trends Pharmacol Sci; 2004 Feb; 25(2):72-5. PubMed ID: 15102492
[TBL] [Abstract][Full Text] [Related]
13. Reduction of early vein graft thrombosis by tissue plasminogen activator gene transfer.
Thomas AC; Wyatt MJ; Newby AC
Thromb Haemost; 2009 Jul; 102(1):145-52. PubMed ID: 19572079
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.
Tiukinhoy-Laing SD; Huang S; Klegerman M; Holland CK; McPherson DD
Thromb Res; 2007; 119(6):777-84. PubMed ID: 16887172
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes.
Murciano JC; Medinilla S; Eslin D; Atochina E; Cines DB; Muzykantov VR
Nat Biotechnol; 2003 Aug; 21(8):891-6. PubMed ID: 12845330
[TBL] [Abstract][Full Text] [Related]
16. Retroviral gene transfer of tissue-type plasminogen activator targets thrombolysis in vitro and in vivo.
Gong YS; Zhang KL; Jiang XG; Wang ZW; Sun ZQ; Cai J
Gene Ther; 2007 Nov; 14(21):1537-42. PubMed ID: 17728795
[TBL] [Abstract][Full Text] [Related]
17. Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.
Kandadai MA; Meunier JM; Hart K; Holland CK; Shaw GJ
Transl Stroke Res; 2015 Feb; 6(1):78-87. PubMed ID: 25411015
[TBL] [Abstract][Full Text] [Related]
18. Structure and activity of plasmin and other direct thrombolytic agents.
Novokhatny V
Thromb Res; 2008; 122 Suppl 3():S3-8. PubMed ID: 18718639
[TBL] [Abstract][Full Text] [Related]
19. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device.
Delgado R; Frazier OH; Myers TJ; Gregoric ID; Robertson K; Shah NA; Kar B
J Heart Lung Transplant; 2005 Feb; 24(2):231-3. PubMed ID: 15701444
[TBL] [Abstract][Full Text] [Related]
20. Effects of intrathrombic administration of prostaglandin E1 during pulse-spray thrombolysis with tissue-type plasminogen activator in experimental thrombosis.
Valji K; Bookstein JJ
Radiology; 1993 Mar; 186(3):873-6. PubMed ID: 8430201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
